BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 28381645)

  • 1. Effect of position-specific single-point mutations and biophysical characterization of amyloidogenic peptide fragments identified from lattice corneal dystrophy patients.
    Anandalakshmi V; Murugan E; Leng EGT; Ting LW; Chaurasia SS; Yamazaki T; Nagashima T; George BL; Peh GSL; Pervushin K; Lakshminarayanan R; Mehta JS
    Biochem J; 2017 May; 474(10):1705-1725. PubMed ID: 28381645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic Analysis of Amyloid Corneal Aggregates from TGFBI-H626R Lattice Corneal Dystrophy Patient Implicates Serine-Protease HTRA1 in Mutation-Specific Pathogenesis of TGFBIp.
    Venkatraman A; Dutta B; Murugan E; Piliang H; Lakshminaryanan R; Sook Yee AC; Pervushin KV; Sze SK; Mehta JS
    J Proteome Res; 2017 Aug; 16(8):2899-2913. PubMed ID: 28689406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two phenotypically distinct lattice corneal dystrophies caused by mutations in the transforming growth factor beta induced (TGFBI) gene.
    Poulsen ET; Runager K; Risør MW; Dyrlund TF; Scavenius C; Karring H; Praetorius J; Vorum H; Otzen DE; Klintworth GK; Enghild JJ
    Proteomics Clin Appl; 2014 Apr; 8(3-4):168-77. PubMed ID: 24302499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serine protease HtrA1 accumulates in corneal transforming growth factor beta induced protein (TGFBIp) amyloid deposits.
    Karring H; Poulsen ET; Runager K; Thøgersen IB; Klintworth GK; Højrup P; Enghild JJ
    Mol Vis; 2013; 19():861-76. PubMed ID: 23592924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibril Core of Transforming Growth Factor Beta-Induced Protein (TGFBIp) Facilitates Aggregation of Corneal TGFBIp.
    Sørensen CS; Runager K; Scavenius C; Jensen MM; Nielsen NS; Christiansen G; Petersen SV; Karring H; Sanggaard KW; Enghild JJ
    Biochemistry; 2015 May; 54(19):2943-56. PubMed ID: 25910219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of osmolytes on in-vitro aggregation properties of peptides derived from TGFBIp.
    Venkatraman A; Murugan E; Lin SJ; Peh GSL; Rajamani L; Mehta JS
    Sci Rep; 2020 Mar; 10(1):4011. PubMed ID: 32132634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical properties and aggregation propensity of transforming growth factor-induced protein (TGFBIp) and the amyloid forming mutants.
    Lakshminarayanan R; Chaurasia SS; Murugan E; Venkatraman A; Chai SM; Vithana EN; Beuerman RW; Mehta JS
    Ocul Surf; 2015 Jan; 13(1):9-25. PubMed ID: 25557343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphic fibrillation of the destabilized fourth fasciclin-1 domain mutant A546T of the Transforming growth factor-β-induced protein (TGFBIp) occurs through multiple pathways with different oligomeric intermediates.
    Andreasen M; Nielsen SB; Runager K; Christiansen G; Nielsen NC; Enghild JJ; Otzen DE
    J Biol Chem; 2012 Oct; 287(41):34730-42. PubMed ID: 22893702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LASIK surgery of granular corneal dystrophy type 2 patients leads to accumulation and differential proteolytic processing of transforming growth factor beta-induced protein (TGFBIp).
    Poulsen ET; Nielsen NS; Jensen MM; Nielsen E; Hjortdal J; Kim EK; Enghild JJ
    Proteomics; 2016 Feb; 16(3):539-43. PubMed ID: 26864644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human phenotypically distinct TGFBI corneal dystrophies are linked to the stability of the fourth FAS1 domain of TGFBIp.
    Runager K; Basaiawmoit RV; Deva T; Andreasen M; Valnickova Z; Sørensen CS; Karring H; Thøgersen IB; Christiansen G; Underhaug J; Kristensen T; Nielsen NC; Klintworth GK; Otzen DE; Enghild JJ
    J Biol Chem; 2011 Feb; 286(7):4951-8. PubMed ID: 21135107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The serine protease HtrA1 cleaves misfolded transforming growth factor β-induced protein (TGFBIp) and induces amyloid formation.
    Poulsen ET; Nielsen NS; Scavenius C; Mogensen EH; Risør MW; Runager K; Lukassen MV; Rasmussen CB; Christiansen G; Richner M; Vorum H; Enghild JJ
    J Biol Chem; 2019 Aug; 294(31):11817-11828. PubMed ID: 31197037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix-Assisted Laser Desorption Ionization Mass Spectrometry Imaging of Key Proteins in Corneal Samples from Lattice Dystrophy Patients with TGFBI-H626R and TGFBI-R124C Mutations.
    Venkatraman A; Hochart G; Bonnel D; Stauber J; Shimmura S; Rajamani L; Pervushin K; Mehta JS
    Proteomics Clin Appl; 2019 Jan; 13(1):e1800053. PubMed ID: 30387319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary lattice corneal dystrophy is associated with corneal amyloid deposits enclosing C-terminal fragments of keratoepithelin.
    Stix B; Leber M; Bingemer P; Gross C; Rüschoff J; Fändrich M; Schorderet DF; Vorwerk CK; Zacharias M; Roessner A; Röcken C
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1133-9. PubMed ID: 15790870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical modulation of the proteolytic profile of Transforming Growth Factor Beta induced protein (TGFBIp) offers a new avenue for treatment of
    Venkatraman A; Duong-Thi MD; Pervushin K; Ohlson S; Mehta JS
    J Adv Res; 2020 Jul; 24():529-543. PubMed ID: 32637173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Composition and proteolytic processing of corneal deposits associated with mutations in the TGFBI gene.
    Karring H; Runager K; Thøgersen IB; Klintworth GK; Højrup P; Enghild JJ
    Exp Eye Res; 2012 Mar; 96(1):163-70. PubMed ID: 22155582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation in transforming growth factor beta induced protein associated with granular corneal dystrophy type 1 reduces the proteolytic susceptibility through local structural stabilization.
    Underhaug J; Koldsø H; Runager K; Nielsen JT; Sørensen CS; Kristensen T; Otzen DE; Karring H; Malmendal A; Schiøtt B; Enghild JJ; Nielsen NC
    Biochim Biophys Acta; 2013 Dec; 1834(12):2812-22. PubMed ID: 24129074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and genetic aspects of the TGFBI-associated corneal dystrophies.
    Lakshminarayanan R; Chaurasia SS; Anandalakshmi V; Chai SM; Murugan E; Vithana EN; Beuerman RW; Mehta JS
    Ocul Surf; 2014 Oct; 12(4):234-51. PubMed ID: 25284770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical mechanisms of aggregation in TGFBI-linked corneal dystrophies.
    Nielsen NS; Poulsen ET; Lukassen MV; Chao Shern C; Mogensen EH; Weberskov CE; DeDionisio L; Schauser L; Moore TCB; Otzen DE; Hjortdal J; Enghild JJ
    Prog Retin Eye Res; 2020 Jul; 77():100843. PubMed ID: 32004730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and Functional Implications of Human Transforming Growth Factor β-Induced Protein, TGFBIp, in Corneal Dystrophies.
    García-Castellanos R; Nielsen NS; Runager K; Thøgersen IB; Lukassen MV; Poulsen ET; Goulas T; Enghild JJ; Gomis-Rüth FX
    Structure; 2017 Nov; 25(11):1740-1750.e2. PubMed ID: 28988748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation-induced dimerization of transforming growth factor-β-induced protein may drive protein aggregation in granular corneal dystrophy.
    Nielsen NS; Gadeberg TAF; Poulsen ET; Harwood SL; Weberskov CE; Pedersen JS; Andersen GR; Enghild JJ
    J Biol Chem; 2021 Jul; 297(1):100858. PubMed ID: 34097874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.